keyword
https://read.qxmd.com/read/38652267/comprehension-of-the-photoinduced-charge-transfer-assisted-energy-transfer-in-gd-3-based-host-sensitized-tellurate-phosphors-for-thermal-sensing-and-anticounterfeiting-labels
#1
JOURNAL ARTICLE
Bhagyalekshmi G L, Subodh Ganesanpotti
A series of novel Eu3+ -activated Ba2 Gd2/3 TeO6 (BGT) phosphors were successfully synthesised via a high temperature solid state reaction method. The crystal structure analysis showed that Eu3+ -doped Ba2 Gd2/3 TeO6 double perovskite phosphors possess monoclinic symmetry with space group P 21 / n . The as-prepared phosphors can be efficiently excited by far-ultraviolet light to generate reddish orange luminescence of around 593 nm corresponding to the 5 D0 → 7 F1 transitions of Eu3+ ions. Gd3+ acts as a sensitizer for luminescence enhancement...
April 23, 2024: Dalton Transactions: An International Journal of Inorganic Chemistry
https://read.qxmd.com/read/38650487/color-tunable-luminescence-and-temperature-sensing-properties-of-bi-3-sm-3-or-bi-3-eu-3-codoped-ba-2-gd-2-ge-4-o-13-phosphors
#2
JOURNAL ARTICLE
Olga A Lipina, Anastasia V Chvanova, Ludmila L Surat, Yana V Baklanova, Alexander Yu Chufarov, Alexander P Tyutyunnik, Vladimir G Zubkov
Novel temperature-sensitive luminescent materials, Ba2 Gd2 Ge4 O13 doped with Bi3+ , Bi3+ /Sm3+ or Bi3+ /Eu3+ ions, have been prepared using a conventional solid-state reaction technique. The XRPD study has verified that all the synthesized germanates crystallize in the monoclinic system (space group C 2/ c , Z = 4). The crystal lattice of the compounds consists of zigzag chains of edge-sharing Me2 O7 (Me = Bi3+ , Eu3+ or Sm3+ ) dimers, [Ge4 O13 ] units, and ten-coordinated Ba atoms. Under UV excitation the powders exhibit the luminescence corresponding to the 3 P1 → 1 S0 (310-550 nm) transition in Bi3+ and 4 G5/2 → 6 H J (550-730 nm) in Sm3+ or 5 D0 → 7 F J (570-720 nm) transitions in Eu3+ ions...
April 23, 2024: Dalton Transactions: An International Journal of Inorganic Chemistry
https://read.qxmd.com/read/38617948/the-gd-2-o-3-gdsrfeo-4-pseudo-binary-phase-diagram
#3
JOURNAL ARTICLE
K M Kenges, A A Krasilin, Е А Тugova
The Gd2 O3 - GdSrFeO4 pseudo-binary phase diagram is presented for the first time. The liquidus and eutectic temperatures, metatectic points of the Gd2 O3 transformations in the Gd2 O3 - GdSrFeO4 section were defined using the Schröder-Le Chatelier equation, neglecting the effect of the isobaric heat capacity. The calculations were based on experimental data on the melting points of the end-members and the eutectic composition. From the results of phase relationships studies (subsolidus and high temperature region including literature data as well) and the above approach the Gd2O3-GdSrFeO4 pseudo-binary phase diagram in the temperature range 1400-2410 °C in air was constructed...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38617529/a-review-on-gaucher-disease-therapeutic-potential-of-%C3%AE-glucocerebrosidase-targeted-mrna-sarna-approach
#4
REVIEW
Shunping Feng, Nino Rcheulishvili, Xiaoming Jiang, Pan Zhu, Xuehua Pan, Meilan Wei, Peng George Wang, Yang Ji, Dimitri Papukashvili
Gaucher disease (GD), a rare hereditary lysosomal storage disorder, occurs due to a deficiency in the enzyme β-glucocerebrosidase (GCase). This deficiency leads to the buildup of substrate glucosylceramide (GlcCer) in macrophages, eventually resulting in various complications. Among its three types, GD2 is particularly severe with neurological involvements. Current treatments, such as enzyme replacement therapy (ERT), are not effective for GD2 and GD3 due to their inability to cross the blood-brain barrier (BBB)...
2024: International Journal of Biological Sciences
https://read.qxmd.com/read/38601159/choosing-t-cell-sources-determines-car-t-cell-activity-in-neuroblastoma
#5
JOURNAL ARTICLE
Lorena García-García, Elena G Sánchez, Mariya Ivanova, Keren Pastora, Cristina Alcántara-Sánchez, Jorge García-Martínez, Beatriz Martín-Antonio, Manuel Ramírez, África González-Murillo
INTRODUCTION: The clinical success of chimeric antigen receptor-modified T cells (CAR-T cells) for hematological malignancies has not been reproduced for solid tumors, partly due to the lack of cancer-type specific antigens. In this work, we used a novel combinatorial approach consisting of a versatile anti-FITC CAR-T effector cells plus an FITC-conjugated neuroblastoma (NB)-targeting linker, an FITC-conjugated monoclonal antibody (Dinutuximab) that recognizes GD2. METHODS: We compared cord blood (CB), and CD45RA-enriched peripheral blood leukapheresis product (45RA) as allogeneic sources of T cells, using peripheral blood (PB) as a control to choose the best condition for anti-FITC CAR-T production...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38593230/preclinical-development-of-car-t-cells-with-antigen-inducible-il18-enforcement-to-treat-gd2-positive-solid-cancers
#6
JOURNAL ARTICLE
Lena Fischer-Riepe, Sareetha Kailayangiri, Katharina Zimmermann, Rita Pfeifer, Michael Aigner, Bianca Altvater, Sascha Kretschmann, Simon Völkl, Jordan Hartley, Celine Dreger, Katja Petry, Andreas Bosio, Angelika von Döllen, Wolfgang Hartmann, Holger Lode, Dennis Görlich, Andreas Mackensen, Melanie Jungblut, Axel Schambach, Hinrich Abken, Claudia Rossig
PURPOSE: Cytokine-engineering of chimeric antigen receptor-redirected T cells (CAR T cells) is a promising principle to overcome the limited activity of canonical CAR T cells against solid cancers. EXPERIMENTAL DESIGN: We developed an investigational medicinal product, GD2IL18CART, consisting of CAR T cells directed against ganglioside GD2 with CAR-inducible IL18 to enhance their activation response and cytolytic effector functions in the tumor microenvironment...
April 9, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38585889/rbm39-degrader-invigorates-natural-killer-cells-to-eradicate-neuroblastoma-despite-cancer-cell-plasticity
#7
Shivendra Singh, Jie Fang, Hongjian Jin, Lee-Ann Van de Velde, Qiong Wu, Andrew Cortes, Christopher L Morton, Mary A Woolard, Waise Quarni, Jacob A Steele, Jon P Connelly, Liusheng He, Rebecca Thorne, Gregory Turner, Thomas Confer, Melissa Johnson, William V Caufield, Burgess B Freeman, Timothy Lockey, Shondra M Pruett-Miller, Ruoning Wang, Andrew M Davidoff, Paul G Thomas, Jun Yang
The cellular plasticity of neuroblastoma is defined by a mixture of two major cell states, adrenergic (ADRN) and mesenchymal (MES), which may contribute to therapy resistance. However, how neuroblastoma cells switch cellular states during therapy remains largely unknown and how to eradicate neuroblastoma regardless of their cell states is a clinical challenge. To better understand the lineage switch of neuroblastoma in chemoresistance, we comprehensively defined the transcriptomic and epigenetic map of ADRN and MES types of neuroblastomas using human and murine models treated with indisulam, a selective RBM39 degrader...
March 25, 2024: bioRxiv
https://read.qxmd.com/read/38566011/decoding-the-reactivity-enhancement-of-ln-2-ce-2-o-7-compounds-ln-yb-y-tb-and-gd-for-soot-combustion-the-remarkable-contribution-of-variable-valence-a-sites
#8
JOURNAL ARTICLE
Shijing Zhang, Junwei Xu, Zekai Xu, Yuting Li, Ping Wang, Lu Xiao, Jiating Shen, Xiuzhong Fang, Xianglan Xu, Xiang Wang
The impact of variable valence A-sites on the redox property and reactivity of Ln2 Ce2 O7 compounds in soot particulate combustion has been investigated. It was observed that Yb2 Ce2 O7 , Y2 Ce2 O7 , and Gd2 Ce2 O7 formed a rare earth C-type phase, while Tb2 Ce2 O7 formed a solid solution phase. Both Tb2 Ce2 O7 and Yb2 Ce2 O7 possess dual valence state A-sites, resulting in significantly more surface vacancies. Additionally, the advantageous solid solution phase structure of Tb2 Ce2 O7 leads to even more surface vacancies than Yb2 Ce2 O7 , which is crucial to generate active oxygen sites...
April 2, 2024: Inorganic Chemistry
https://read.qxmd.com/read/38564260/effect-of-diamagnetic-zn-ii-ions-on-the-smm-properties-of-a-series-of-trinuclear-zndy-2-and-tetranuclear-zn-2-dy-2-ln-iii-dy-tb-gd-complexes-combined-experimental-and-theoretical-studies
#9
JOURNAL ARTICLE
Pooja Shukla, Ibtesham Tarannum, Soumalya Roy, Amit Rajput, Prem Lama, Saurabh Kumar Singh, Julia Kłak, Junseong Lee, Sourav Das
To study the effect of diamagnetic ions on magnetic interactions, utilizing a compartmental ligand ( Z )-2-(hydroxymethyl)-4-methyl-6-((quinolin-8-ylimino)methyl)phenol (LH2 ), two different series of ZnII -LnIII complexes, namely the trinuclear series of [DyZn2 (L)2 (μ2 -OAc)2 (CH3 OH)2 ]·NO3 ·MeOH (1), [TbZn2 (L)2 (μ2 -OAc)2 (CH3 OH)2 ]·NO3 ·5MeOH·H2 O (2), and [GdZn2 (L)2 (μ2 -OAc)2 (CH3 OH)2 ]·NO3 ·MeOH·CHCl3 (3) and the tetranuclear series of [Dy2 Zn2 (LH)4 (NO3 )4 (μ2 OAc)]·NO3 ·MeOH·H2 O (4), [Tb2 Zn2 (LH)4 (NO3 )4 (μ2 -OAc)]·NO3 ·MeOH·2H2 O (5), and [Gd2 Zn2 (LH)4 (NO3 )4 (μ2 -OAc)]·NO3 ·MeOH·2H2 O (6), were synthesized...
April 2, 2024: Dalton Transactions: An International Journal of Inorganic Chemistry
https://read.qxmd.com/read/38562720/metabolic-priming-of-gd2-trac-car-t-cells-during-manufacturing-promotes-memory-phenotypes-while-enhancing-persistence
#10
Dan Cappabianca, Dan Pham, Matthew H Forsberg, Madison Bugel, Anna Tommasi, Anthony Lauer, Jolanta Vidugiriene, Brookelyn Hrdlicka, Alexandria McHale, Quaovi Sodji, Melissa C Skala, Christian M Capitini, Krishanu Saha
Manufacturing Chimeric Antigen Receptor (CAR) T cell therapies is complex, with limited understanding of how media composition impact T-cell phenotypes. CRISPR/Cas9 ribonucleoproteins can precisely insert a CAR sequence while disrupting the endogenous T cell receptor alpha constant ( TRAC ) gene resulting in TRAC -CAR T cells with an enriched stem cell memory T-cell population, a process that could be further optimized through modifications to the media composition. In this study we generated anti-GD2 TRAC -CAR T cells using "metabolic priming" (MP), where the cells were activated in glucose/glutamine low media and then expanded in glucose/glutamine high media...
March 19, 2024: bioRxiv
https://read.qxmd.com/read/38559042/conditional-c-myc-activation-in-catecholaminergic-cells-drives-distinct-neuroendocrine-tumors-neuroblastoma-vs-somatostatinoma
#11
Tingting Wang, Lingling Liu, Jie Fang, Hongjian Jin, Sivaraman Natarajan, Heather Sheppard, Meifen Lu, Gregory Turner, Thomas Confer, Melissa Johnson, Jeffrey Steinberg, Larry Ha, Nour Yadak, Richa Jain, David J Picketts, Xiaotu Ma, Andrew Murphy, Andrew M Davidoff, Evan S Glazer, John Easton, Xiang Chen, Ruoning Wang, Jun Yang
The MYC proto-oncogenes (c-MYC, MYCN , MYCL ) are among the most deregulated oncogenic drivers in human malignancies including high-risk neuroblastoma, 50% of which are MYCN -amplified. Genetically engineered mouse models (GEMMs) based on the MYCN transgene have greatly expanded the understanding of neuroblastoma biology and are powerful tools for testing new therapies. However, a lack of c-MYC-driven GEMMs has hampered the ability to better understand mechanisms of neuroblastoma oncogenesis and therapy development given that c-MYC is also an important driver of many high-risk neuroblastomas...
March 14, 2024: bioRxiv
https://read.qxmd.com/read/38558810/gd2-targeting-therapy-a-comparative-analysis-of-approaches-and-promising-directions
#12
REVIEW
Julia Philippova, Julia Shevchenko, Sergey Sennikov
Disialoganglioside GD2 is a promising target for immunotherapy with expression primarily restricted to neuroectodermal and epithelial tumor cells. Although its role in the maintenance and repair of neural tissue is well-established, its functions during normal organism development remain understudied. Meanwhile, studies have shown that GD2 plays an important role in tumorigenesis. Its functions include proliferation, invasion, motility, and metastasis, and its high expression and ability to transform the tumor microenvironment may be associated with a malignant phenotype...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38551501/gd2-targeting-car-t-cell-therapy-for-patients-with-gd2-medulloblastoma
#13
JOURNAL ARTICLE
Roselia Ciccone, Concetta Quintarelli, Antonio Camera, Michele Pezzella, Simona Caruso, Simona Manni, Alessio Ottaviani, Marika Guercio, Francesca Del Bufalo, Maria Cecilia Quadraccia, Domenico Orlando, Stefano Di Cecca, Matilde Sinibaldi, Mariasole Aurigemma, Laura Iaffaldano, Andrea Sarcinelli, Maria Luisa D' Amore, Manuela Ceccarelli, Francesca Nazio, Veronica Marabitti, Ezio Giorda, Marco Pezzullo, Cristiano De Stefanis, Andrea Carai, Sabrina Rossi, Rita Alaggio, Giada Del Baldo, Marco Becilli, Angela Mastronuzzi, Biagio De Angelis, Franco Locatelli
PURPOSE: Medulloblastoma (MB), the most common childhood malignant brain tumor, has a poor prognosis in about 30% of patients. The current standard of care, which includes surgery, radiation and chemotherapy, is often responsible for cognitive, neurologic and endocrine side effects. We investigated whether chimeric antigen receptor (CAR) T-cells directed towards the disialoganglioside GD2 can represent a potentially more effective treatment with reduced long-term side effects. EXPERIMENTAL DESIGN: GD2 expression was evaluated on primary tumor biopsies of MB children by flow-cytometry...
March 29, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38537429/mass-manufacturable-scintillation-based-optical-fiber-dosimeters-for-brachytherapy
#14
JOURNAL ARTICLE
Agnieszka Gierej, Tigran Baghdasaryan, Michael Martyn, Peter Woulfe, Owen Mc Laughlin, Kevin Prise, Geraldine Workman, Sinead O'Keeffe, Kurt Rochlitz, Sergey Verlinski, Agnese Giaz, Romualdo Santoro, Massimo Caccia, Francis Berghmans, Jürgen Van Erps
Scintillation-based fiber dosimeters are a powerful tool for minimally invasive localized real-time monitoring of the dose rate during Low Dose Rate (LDR) and High Dose Rate (HDR) brachytherapy (BT). This paper presents the design, fabrication, and characterization of such dosimeters, consisting of scintillating sensor tips attached to polymer optical fiber (POF). The sensor tips consist of inorganic scintillators, i.e. Gd2 O2 S:Tb for LDR-BT, and Y2 O3 :Eu+4YVO4 :Eu for HDR-BT, dispersed in a polymer host...
March 21, 2024: Biosensors & Bioelectronics
https://read.qxmd.com/read/38522240/an-anti-gd2-aptamer-based-bifunctional-spherical-nucleic-acid-nanoplatform-for-synergistic-therapy-targeting-mdm2-for-retinoblastoma
#15
JOURNAL ARTICLE
Shijing Wang, Yan Zhao, Fei Yao, Pengxue Wei, Lan Ma, Shaochong Zhang
Retinoblastoma (RB) is a type of pediatric solid tumor in the fundus. The lack of precision therapies combined with the difficulty of delivering small interfering RNA (siRNA) into the eyes means that there is currently no nucleic acid-based therapy for RB in clinical practice. Here, we reported on anti-GD2 and glutathione-responsive spherical nucleic acids (SNAs), loaded with siRNA and the inhibitor NVP-CGM097, which jointly blocked the oncogenic factor n in RB cells (Y79 and WERI-RB-1). The SNAs were formed through the self-assembly of bifunctional cholesterol amphiphiles containing aptamers that specifically targeted GD2-positive RB cells, allowing for the formation of an SNA with a dense DNA shell...
March 22, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38519053/targeting-refractory-recurrent-neuroblastoma-and-osteosarcoma-with-anti-cd3%C3%A3-anti-gd2-bispecific-antibody-armed-t-cells
#16
JOURNAL ARTICLE
Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub, Alissa Martin, Dana Schalk, Amy Schienshang, Sarah Whitaker, Katie Rea, Daniel W Lee, Qin Liu, Anthony F Shields, Nai-Kong V Cheung, Lawrence G Lum
BACKGROUND: The survival benefit observed in children with neuroblastoma (NB) and minimal residual disease who received treatment with anti-GD2 monoclonal antibodies prompted our investigation into the safety and potential clinical benefits of anti-CD3×anti-GD2 bispecific antibody (GD2Bi) armed T cells (GD2BATs). Preclinical studies demonstrated the high cytotoxicity of GD2BATs against GD2+cell lines, leading to the initiation of a phase I/II study in recurrent/refractory patients...
March 21, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38509388/adult-type-i-gaucher-disease-with-splenectomy-caused-by-a-compound-heterozygous-gba1-mutation-in-a-chinese-patient-a-case-report
#17
JOURNAL ARTICLE
Jian-Hui Zhang, Hui Chen, Dan-Dan Ruan, Ying Chen, Li Zhang, Mei-Zhu Gao, Qian Chen, Hong-Ping Yu, Jia-Yi Wu, Xin-Fu Lin, Zhu-Ting Fang, Xiao-Ling Zheng, Jie-Wei Luo, Li-Sheng Liao, Hong Li
Gaucher disease (GD) is an autosomal recessive ailment resulting from glucocerebrosidase deficiency caused by a mutation in the GBA1 gene, leading to multi-organ problems in the liver, spleen, and bone marrow. In China, GD is extremely uncommon and has a lower incidence rate than worldwide. In this study, we report the case of an adult male with an enlarged spleen for 13 years who presented with abdominal distension, severe loss of appetite and weight, reduction of the three-line due to hypersplenism, frequent nosebleeds, and bloody stools...
March 20, 2024: Annals of Hematology
https://read.qxmd.com/read/38495105/silencing-of-the-phlda1-leads-to-global-proteome-changes-and-differentiation-pathways-of-human-neuroblastoma-cells
#18
JOURNAL ARTICLE
Beata Bugara, Małgorzata Durbas, Maja Kudrycka, Agata Malinowska, Irena Horwacik, Hanna Rokita
Neuroblastoma (NB) is the most common extracranial pediatric solid tumor originating from the abnormal development of cells of the sympathoadrenal lineage of the neural crest. Targeting GD2 ganglioside (GD2), a glycolipid expressed on neuroblastoma cells, with GD2 ganglioside-recognizing antibodies affects several pivotal signaling routes that drive or influence the malignant phenotype of the cells. Previously performed gene expression profiling helped us to identify the PHLDA1 (pleckstrin homology-like domain family A member 1) gene as the most upregulated gene in the IMR-32 human neuroblastoma cells treated with the mouse 14G2a monoclonal antibody...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38489858/chemo-immunotherapy-with-dinutuximab-beta-in-patients-with-relapsed-progressive-high-risk-neuroblastoma-does-chemotherapy-backbone-matter
#19
JOURNAL ARTICLE
Patricia Raiser, Gudrun Schleiermacher, Marion Gambart, Benoit Dumont, Anne-Sophie Defachelles, Estelle Thebaud, Julie Tandonnet, Claudia Pasqualini, Stéphanie Proust, Natacha Entz-Werle, Isabelle Aerts, Lee A Ndounga-Diakou, Arnaud Petit, Chloe Puiseux, Camille Khanfar, Jeremie Rouger, Ludovic Mansuy, Joy Benadiba, Frédéric Millot, Claire Pluchart, Salim Laghouati, Birgit Geoerger, Gilles Vassal, Dominique Valteau-Couanet, Pablo Berlanga
BACKGROUND: Addition of anti-GD2 antibodies to temozolomide-based chemotherapy has demonstrated increased antitumor activity and progression-free survival in patients with relapsed/progressive high-risk neuroblastoma. However, chemo-immunotherapy is not yet approved for this indication. This study presents the chemo-immunotherapy experience in patients with relapsed/progressive high-risk neuroblastoma treated within the off-label use program of the Neuroblastoma Committee of the French Society of Pediatric Oncology (SFCE)...
May 2024: European Journal of Cancer
https://read.qxmd.com/read/38474638/preparation-and-characterization-of-bilayer-polymer-dispersed-liquid-crystals-doped-with-gd-2-o-3-nanoparticles-and-rhodamine-b-base-fluorescent-dye
#20
JOURNAL ARTICLE
Yongle Wu, Yuzhen Zhao, Xun Li, Hong Gao, Zhun Guo, Dong Wang, Yi Luan, Lei Wang
Using the polymerization-induced phase separation (PIPS) method, bilayer polymer-dispersed liquid crystal (PDLC) films with a PDLC-PVA-PDLC structure were prepared in this work. It was found that all PDLC performance indexes were affected by polymer mesh size after comparing the microscopic morphology and electro-optical properties of samples with different monomer ratios. Gd2 O3 nanoparticles and rhodamine B base fluorescent dyes introduced into the bilayer PDLC optimized the samples' electro-optical properties and developed new functionalities...
March 2, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
keyword
keyword
9789
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.